Macrophages lacking TSC2 have mTORC1-dependent increased GPNMB and ameliorate ventricular dysfunction/remodeling after ischemia-reperfusion. [PDF]
Keykhaei M +10 more
europepmc +1 more source
mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis. [PDF]
Babaei-Jadidi R +12 more
europepmc +1 more source
High-throughput bioprinting to produce micropatterned neuroepithelial tissues and model TSC2-deficient brain malformations. [PDF]
Imani Farahani N +6 more
europepmc +1 more source
Amino acid-dependent TSC2 dephosphorylation by lysosome-PP2A regulates mTORC1 signaling transduction. [PDF]
Nakamura T +11 more
europepmc +1 more source
Nanomedicine for lymphangioleiomyomatosis: toward targeted and durable anti-fibrotic therapy. [PDF]
Lal AA +4 more
europepmc +1 more source
Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in <i>TSC2</i>-Deficient and Cancer Cells. [PDF]
Tahsin T +13 more
europepmc +1 more source
NEAT1 Promotes Epileptogenesis in Tuberous Sclerosis Complex. [PDF]
Kuang S +8 more
europepmc +1 more source
A Rare Intra-Atrial Cyst of Vascular Origin: Genetic Insights From a Case. [PDF]
Wang T +7 more
europepmc +1 more source
A Case of TSC2/PKD1 Contiguous Gene Deletion Syndrome With Proven Kidney Pathology. [PDF]
Kamitani R +6 more
europepmc +1 more source

